|
|
Study on the Medical and Economic Values of High Dose Bovine Alveolar Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome |
CHEN Kun, QIN Huajun |
Chongqing Three Gorges Central Hospital, Chongqing 404000, China |
|
|
Abstract Objective: To investigate the clinical and economic values of high dose bovine alveolar surfactant (PS) in the treatment of neonatal respiratory distress syndrome (NRDS).Methods: 90 cases of NRDS diagnosed and treated in the Department of Pediatrics of our hospital from February 2017 to August 2019 were prospectively selected and divided into the routine group and the study group with the simple random number table method, 45 cases in each group.All NRDS patients were treated with CPAP, expectoration and anti infection.70 mg / kg standard dose and 100 mg / kg high dose PS were injected into tracheal intubation in routine group and study group respectively.The changes of blood gas analysis indexes (PaO2, PaO2, pH) and ventilator parameters (PEEP, FiO2, RI) were observed before and 48 hours after treatment, and the CPAP time, PS medication times, complication rate, mortality, length of hospital stay and total medical expenses were recorded.Results: Values of PaO2, pH and PEEP were significantly increased and PaCO2, FiO2 and RI were significantly decreased in the two groups 48 hours after treatment, and the difference was statistically significant (P<0.05).Values of PaO2, pH, PEEP, PaCO2, FiO2 and RI of the study group were significantly higher than those of the control group.The difference was statistically significant (P<0.05).The complication rate and mortality rate of NRDS in the study group were 8.89% and 2.22% respectively, which were slightly lower than those in the control group (13.33% and 4.44%).There was no significant difference (P>0.05).The time of CPAP and the times of PS administration in the study group were lower than those in the control group (P<0.05).The length of stay and the total cost of medical treatment in the study group were less than those in the routine group, and the difference was statistically significant (P<0.05).Compared with the standard dose of 70 mg / kg PS in the treatment of NRDS, the high dose of 100 mg / kg PS can save about 7200 yuan / case of medical expenses, and the total savings of 45 NRDS patients in the study group are about 324000 yuan.Conclusion: Compared with the standard dose of 70 mg / kg PS in the treatment of NRDS, the effect of high dose of 100 mg / kg PS is better, with significant clinical and economic values.
|
|
|
|
|
[1] 冯爱民,谢秀春,王苗,等.肺表面活性物质联合无创高频振荡通气治疗新生儿呼吸窘迫综合征的效果观察[J].河北医学,2019,25(3):551~555. [2] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.2011.395~398. [3] 陈曦,陈晓.不同肺泡表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较[J].江西医药,2019,54(4):392~394. [4] Bae CW,Kim CY,Chung SH,et al.History of pulmonary surfactant replacement therapy for neonatal respiratory distress syndrome in korea[J].Journal of Korean medical science,2019,34(25):175~182. [5] 程燕,王斌.足月儿和晚期早产儿急性呼吸窘迫综合征[J].中华产科急救电子杂志,2017,6(4):203~206. [6] 刘莺,孟远翠.不同起始量牛肺泡表面活性物质对早产儿呼吸窘迫综合征的临床疗效比较[J].陕西医学杂志,2017,46(12):1685. [7] 蔡绵碧,苏永智,张虹梅,等.小剂量牛肺表面活性物质联合HFOV治疗新生儿呼吸衰竭的临床效果分析[J].深圳中西医结合杂志,2018,28(4):28~29. [8] 熊丽,张连红,孙婷.珂立苏治疗晚期早产儿呼吸窘迫综合征的最佳剂量分析[J].安徽医学,2017,38(4):460~462. |
|
|
|